Skin cancer in epidermodysplasia verruciformis patients from Brazil [18]

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 9, 2006, Pages 1154-1156

  Oliveira, Walmar Roncalli ^a   Rady, P L ^b   Festa, C ^a   Rivitti, E A ^a   Tyring, S K ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b University of Texas Health Science Center at Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC KERATOSIS; ADOLESCENT; ADULT; BRAZIL; CANCER INVASION; CANCER LOCALIZATION; CANCER RISK; CAUCASIAN; CELLULAR IMMUNITY; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNE DEFICIENCY; LETTER; LYMPH NODE METASTASIS; MALE; MALIGNANT TRANSFORMATION; NEGRO; POLYMERASE CHAIN REACTION; PRECANCER; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; TINEA VERSICOLOR; ULTRAVIOLET RADIATION; VIRUS CARCINOGENESIS; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; BRAZIL; CARCINOMA, SQUAMOUS CELL; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; HUMANS; IMMUNITY, CELLULAR; KERATOSIS; MALE; PAPILLOMAVIRUS INFECTIONS; SKIN NEOPLASMS;

EID: 33748890926     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01654.x     Document Type: Letter

References (8)

1. Majewski S, Jablonska S. Epidermodysplasia verruciformis. In: Sterling JC, Tyring SK, eds. Human Papillomaviruses Clinical and Scientific Advances. Oxford University Press, New York, 2001: 90-101.
2. Oliveira WRP, Festa C, Rady P, Tyring SK. Clinical aspects of epidermodysplasia verruciformis. J Eur Acad Derm Venereol 2003; 17: 394-398.
3. Majewski S, Jablonska S, Orth G. Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: Role in tumor progression. Clin Dermatol 1997; 15: 321-332.
4. Oliveira WRP, Carrasco S, Festa C et al. Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis. J Dermatol 2003; 30: 203-209.
5. Oliveira WRP, He Q, Rady P et al. HPV typing in Brazilian patients with epidermodysplasia verruciformis: High prevalence of EV-HPV 25. J Cutan Med Surg 2004: 110-115.
6. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995; 131: 1312-1318.
7. Lutzner MA, Blanchet-Bardon C, Orth G. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J Invest Dermatol 1984; 83: 18s-25s.
8. Jacyk WK, Villiers EM. Epidermodysplasia verruciformis in Africans. Int J Dermatol 1993; 32: 806-810.